NCT00059384View on ClinicalTrials.gov

Alternative Dosing Strategy for Anti-HIV Drugs

PHASE4CompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

January 31, 2003

Primary Completion Date

December 31, 2007

Study Completion Date

December 31, 2007

Conditions
HIV Infections
Interventions
BEHAVIORAL

Concentration-controlled therapy

Trial Locations (1)

80262

University of Colorado Health Sciences Center, Denver

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00059384 - Alternative Dosing Strategy for Anti-HIV Drugs | Biotech Hunter | Biotech Hunter